Medical breakthroughs will face ‘perfect storm’ internationally in 2014

Chicago Daily Law Bulletin  Dec. 5, 2013

In her column, Professor Doris Estelle Long examines the new world of “biologics,” the chemically synthesized drugs that many pharmaceutical companies believe will carry them through the new “patent cliff” as more and more patents expire.

Read More